Punam Malik

6.9k total citations
138 papers, 4.7k citations indexed

About

Punam Malik is a scholar working on Molecular Biology, Genetics and Genetics. According to data from OpenAlex, Punam Malik has authored 138 papers receiving a total of 4.7k indexed citations (citations by other indexed papers that have themselves been cited), including 76 papers in Molecular Biology, 61 papers in Genetics and 47 papers in Genetics. Recurrent topics in Punam Malik's work include Hemoglobinopathies and Related Disorders (59 papers), Virus-based gene therapy research (46 papers) and CRISPR and Genetic Engineering (36 papers). Punam Malik is often cited by papers focused on Hemoglobinopathies and Related Disorders (59 papers), Virus-based gene therapy research (46 papers) and CRISPR and Genetic Engineering (36 papers). Punam Malik collaborates with scholars based in United States, France and Germany. Punam Malik's co-authors include Vijay K. Kalra, Paritha Arumugam, Natalya Perelman, Ping Xia, Donald B. Kohn, Tomoyasu Higashimoto, Fabrizia Urbinati, Marilyn J. Telen, Licheng Zeng and Nitin Patel and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Punam Malik

136 papers receiving 4.6k citations

Peers

Countries citing papers authored by Punam Malik

Since Specialization

Citations

This map shows the geographic impact of Punam Malik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Punam Malik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Punam Malik more than expected).

Fields of papers citing papers by Punam Malik

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Punam Malik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Punam Malik. The network helps show where Punam Malik may publish in the future.

Co-authorship network of co-authors of Punam Malik

This figure shows the co-authorship network connecting the top 25 collaborators of Punam Malik. A scholar is included among the top collaborators of Punam Malik based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Punam Malik. Punam Malik is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A novel mouse model of hemoglobin SC disease reveals mechanisms underlying beneficial effects of hydroxyurea 2025 ·Blood ·Tahereh Setayesh, (unknown), (unknown), Masahide Sakabe, Katie Seu, Zhenqi Zhu, (unknown), (unknown), Mei Xin, (unknown), Kenneth D. Greis, Tim M. Townes, József Balla, (unknown), Yueh‐Chiang Hu, Punam Malik	1
2	Preclinical safety assessment of modified gamma globin lentiviral vector-mediated autologous hematopoietic stem cell gene therapy for hemoglobinopathies 2024 ·PLoS ONE ·Mohammad Shadid, (unknown), Punam Malik	2
3	Preclinical Evaluation of Foamy Virus Vector-Mediated Gene Addition in Human Hematopoietic Stem/Progenitor Cells for Correction of Leukocyte Adhesion Deficiency Type 1 2022 ·Human Gene Therapy ·Richard H. Smith, (unknown), Danielle Fink, Keyvan Keyvanfar, (unknown), (unknown), (unknown), (unknown), Luigi J. Alvarado, Thomas R. Bauer, Dennis D. Hickstein, David W. Russell, Punam Malik, Johannes C.M. van der Loo, Steven L. Highfill, Douglas B. Kuhns, Mehdi Pirooznia, André Larochelle	2
4	Implementation of near‐universal hydroxyurea uptake among children with sickle cell anemia: A single‐center experience 2021 ·Pediatric Blood & Cancer ·(unknown), (unknown), Omar Niss, (unknown), (unknown), Theodosia A. Kalfa, Punam Malik, Charles T. Quinn, Russell E. Ware, Patrick T. McGann	10
5	Safety and Efficacy of Aru-1801 in Patients with Sickle Cell Disease: Early Results from the Phase 1/2 Momentum Study of a Modified Gamma Globin Gene Therapy and Reduced Intensity Conditioning 2021 ·Blood ·Michael Grimley, Monika Asnani, Archana Shrestha, (unknown), Carolyn Lutzko, Paritha Arumugam, Scott R. Witting, Jennifer Knight‐Madden, Omar Niss, Charles T. Quinn, (unknown), (unknown), (unknown), Punam Malik	21
6	Safe and Effective In Vivo Targeting and Gene Editing in Hematopoietic Stem Cells: Strategies for Accelerating Development 2021 ·Human Gene Therapy ·Paula M. Cannon, Aravind Asokan, Agnieszka Czechowicz, Paula T. Hammond, Donald B. Kohn, André Lieber, Punam Malik, Peter Marks, Matthew H. Porteus, Els Verhoeyen, Drew Weissman, Irving L. Weissman, Hans‐Peter Kiem	17
7	Left atrial dysfunction in sickle cell anemia is associated with diffuse myocardial fibrosis, increased right ventricular pressure and reduced exercise capacity 2020 ·Scientific Reports ·Tarek Alsaied, Omar Niss, Justin T. Tretter, Adam W. Powell, Clifford Chin, Robert J. Fleck, James Cnota, Punam Malik, Charles T. Quinn, Sherif F. Nagueh, Michael D. Taylor, Wojciech Mazur	12
8	Progression of albuminuria in patients with sickle cell anemia: a multicenter, longitudinal study 2020 ·Blood Advances ·Omar Niss, Adam Lane, Monika Asnani, Marianne E. Yee, Ashok Raj, Susan E. Creary, Courtney D. Fitzhugh, (unknown), Santosh L. Saraf, Sharada A. Sarnaik, Prasad Devarajan, Punam Malik	33
9	FT-4202, an Allosteric Activator of Pyruvate Kinase-R, Demonstrates Proof of Mechanism and Proof of Concept after a Single Dose and after Multiple Daily Doses in a Phase 1 Study of Patients with Sickle Cell Disease 2020 ·Blood ·R. Clark Brown, (unknown), Theodosia A. Kalfa, Frans A. Kuypers, Santosh L. Saraf, Jeremie H. Estepp, Luke R. Smart, Punam Malik, Mark A. Lerman, (unknown), Maria Ribadeneira, (unknown), Patricia Schroeder, Eric Wu, Patrick Kelly, Marilyn J. Telen	14
10	Early Results from a Phase 1/2 Study of Aru-1801 Gene Therapy for Sickle Cell Disease (SCD): Manufacturing Process Enhancements Improve Efficacy of a Modified Gamma Globin Lentivirus Vector and Reduced Intensity Conditioning Transplant 2020 ·Blood ·Michael Grimley, Monika Asnani, Archana Shrestha, (unknown), Carolyn Lutzko, Paritha Arumugam, Scott R. Witting, Jennifer Knight‐Madden, Omar Niss, Charles T. Quinn, (unknown), (unknown), (unknown), Punam Malik	11
11	Abnormal submaximal cardiopulmonary exercise parameters predict impaired peak exercise performance in sickle cell anemia patients 2019 ·Pediatric Blood & Cancer ·Adam W. Powell, Tarek Alsaied, Omar Niss, Robert J. Fleck, Punam Malik, Charles T. Quinn, Wayne A. Mays, Michael D. Taylor, Clifford Chin	7
12	Elimination of the fibrinogen integrin αMβ2-binding motif improves renal pathology in mice with sickle cell anemia 2019 ·Blood Advances ·(unknown), Paritha Arumugam, Eric S. Mullins, (unknown), (unknown), (unknown), Maureen A. Shaw, Sarah McGraw, Bruce J. Aronow, Punam Malik	17
13	Diastolic dysfunction is associated with exercise impairment in patients with sickle cell anemia 2018 ·Pediatric Blood & Cancer ·Tarek Alsaied, Omar Niss, Adam W. Powell, Robert J. Fleck, James Cnota, Clifford Chin, Punam Malik, Charles T. Quinn, Michael D. Taylor	16
14	p190-B RhoGAP and intracellular cytokine signals balance hematopoietic stem and progenitor cell self-renewal and differentiation 2017 ·Nature Communications ·Ashwini Hinge, Juying Xu, José Javier, (unknown), Sachin Kumar, Reuben Kapur, Edward F. Srour, Punam Malik, Bruce J. Aronow, Marie-Dominique Filippi	35
15	Placenta growth factor augments airway hyperresponsiveness via leukotrienes and IL-13 2015 ·Journal of Clinical Investigation ·(unknown), Eric B. Brandt, Shiva Kumar Shanmukhappa, Paritha Arumugam, Swati Tiwari, (unknown), (unknown), Tilat A. Rizvi, Mark Lindsey, (unknown), Peter Carmeliet, Vijay Kalra, Timothy D. Le Cras, Nancy Ratner, Marsha Wills‐Karp, Gurjit K. Khurana Hershey, Punam Malik	29
16	Use of Induced Pluripotent Stem Cells to Recapitulate Pulmonary Alveolar Proteinosis Pathogenesis 2013 ·American Journal of Respiratory and Critical Care Medicine ·Takuji Suzuki, Christopher N. Mayhew, Anthony Sallese, Claudia Chalk, Brenna Carey, Punam Malik, Robert E. Wood, Bruce C. Trapnell	40
17	Genetic Therapy for Beta-Thalassemia: From the Bench to the Bedside 2010 ·Hematology ·Paritha Arumugam, Punam Malik	28
18	High levels of placenta growth factor in sickle cell disease promote pulmonary hypertension 2010 ·Blood ·Nambirajan Sundaram, Anitaben Tailor, Laurel Mendelsohn, Janaka Wansapura, Xunde Wang, Tomoyasu Higashimoto, Michael W. Pauciulo, William Gottliebson, Vijay K. Kalra, William C. Nichols, Gregory J. Kato, Punam Malik	65
19	Nf1 Mutation Expands an EGFR-Dependent Peripheral Nerve Progenitor that Confers Neurofibroma Tumorigenic Potential 2008 ·Cell stem cell ·Jon Williams, Jianqiang Wu, Gunnar Johansson, Tilat A. Rizvi, (unknown), Hartmut Geiger, Punam Malik, Wenling Li, Yoh‐suke Mukouyama, José A. Cancelas, Nancy Ratner	33
20	Expression of Biologically Active Human Factor IX in Human Hematopoietic Cells after Retroviral Vector-Mediated Gene Transduction 1995 ·Human Gene Therapy ·Qian‐Lin Hao, Punam Malik, (unknown), (unknown), Erlinda M. Gordon, Donald B. Kohn	11

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact